University of Alabama Medicine 2020 ASCO Highlights
2020 ASCO Update on Azacitidine Combinations in AML: Are Aza/Ven/Ivosidenib Combination Well Tolerated and Effective in Patients With IDH1-Mutated Disease?
Login to view comments.
Click here to Login